“From the emergence to the end of Anvisa’s prior consent: a critical analysis of pharmaceutical patenting in Brazil”, Rev. Digit. Direito Adm., vol. 11, no. 1, pp. 307–334, Feb. 2024, doi: 10.11606/issn.2319-0558.v11i1p307-334.